Data as of Aug 01
| -0.30 / -1.42%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 34.00, with a high estimate of 51.00 and a low estimate of 26.00. The median estimate represents a +62.84% increase from the last price of 20.88.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.